1. Analysis of degradation processes of bovine fibrinogen by bovine plasmin using sodium dodecyl sulfate-polyacrylamide gel electrophoresis and a study on the mode of changes of the properties related to clotting of digestion products as a function of time were performed. Gross features and patterns very similar to those which had been reported with human fibrinogen-plasmin systems were obtained. 2. Based on the molecular size of the degradation products and the mode of appearance and disappearance of the degradation products, the processes could tentatively be divided into three stages: stage 1, where fibrinogen (mol. wt 370 000) was degraded to produce fragments X1 (330 000) and X2 (290 000); stage 2, fragment X2 was degraded with appearance of Y (210 000) and D1 (140 000); stage 3, appearance of fragments D1, D2 (110 000), and D3 (100 000) sequentially and E (68 000) with concomitant disappearance of Y. 3. A microseparation method, which is a combination of dansylation and sodium dodecylsulfate-polyacrylamide gel electrophoresis, was devised to analyze the events of stage 1 in detail, and a molecular model for the process was proposed. 4. The plasmic degradation processes of bovine non-cross-linked fibrins in solution and in gel form were compared with that of fibrinogen and it was found that the state of the substrates, fibrins, could cause differences in the degradation patterns. With the former substrate, essentially the same sodium dodecyl sulfate-polyacrylamide gel electrophoretic patterns as those with fibrinogen were obtained. With the latter substrate, however, a distinct difference in the mode of degradation of beta chains was observed.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0005-2795(75)90187-7DOI Listing

Publication Analysis

Top Keywords

plasmic degradation
8
bovine fibrinogen
8
fibrins solution
8
solution gel
8
gel form
8
degradation processes
8
processes bovine
8
sodium dodecyl
8
dodecyl sulfate-polyacrylamide
8
sulfate-polyacrylamide gel
8

Similar Publications

From Ca dysregulation to heart failure: β-adrenoceptor activation by RKIP postpones molecular damages and subsequent cardiac dysfunction in mice carrying mutant PLN by correction of aberrant Ca-handling.

Pharmacol Res

January 2025

Institute of Pharmacology and Toxicology, University of Würzburg, Versbacher Str. 9, Würzburg 97078, Germany; Leibniz-Institut für Analytische Wissenschaften - ISAS - e.V., Bunsen-Kirchhoff-Str. 11, Dortmund 44139, Germany; Comprehensive Heart Failure Center, University Hospital of Würzburg, Am Schwarzenberg 15, Würzburg 97078, Germany. Electronic address:

Article Synopsis
  • Impaired calcium (Ca) handling in heart cells is a key feature of heart failure (HF), leading to issues like weakened heart contractions and irregular heartbeats.
  • The study used transgenic mice with a mutation affecting a calcium regulator (phospholamban) to understand how defects in calcium cycling contribute to HF, noting that these mice experience severe and fast-progressing heart failure.
  • Early treatment aimed at correcting calcium cycling using Raf kinase inhibitor protein (RKIP) was found to delay heart cell damage and improve overall health of the mice, indicating that addressing Ca dynamics early on could be crucial for preventing further complications in heart failure.
View Article and Find Full Text PDF

Dye-contaminated wastewater poses serious environmental risks to ecosystems and human health. Diatoms, algae with nanoporous frustules (cell walls), offer promising potential for wastewater remediation due to their high surface area and adsorption properties. While dead diatom biomass is well-studied for biosorption, research on living diatoms' bioaccumulation and biotransformation potential is limited, with gaps in kinetic and equilibrium modeling of dye adsorption.

View Article and Find Full Text PDF

The sarco (endo)plasmic reticulum Ca-ATPase 2a (SERCA2a)-phospholamban (PLN) system within the sarcoplasmic reticulum is crucial for regulating intracellular Ca cycling in ventricular cardiomyocytes. Given that impaired Ca cycling is associated with heart failure, modulating SERCA2a activity represents a promising therapeutic strategy. Previously, we engineered an RNA aptamer (Apt30) that binds to PLN, thereby activating SERCA2a by alleviating PLN's inhibitory effect.

View Article and Find Full Text PDF

Refining the standard of care in immune thrombotic thrombocytopenic purpura.

Clin Adv Hematol Oncol

October 2024

Division of Hematology and Medical Oncology, NewYork-Presbyterian Hospital and Weill Cornell Medicine, New York, New York.

Article Synopsis
  • Acute immune thrombotic thrombocytopenic purpura (iTTP) is a serious condition that requires immediate medical attention and tests to see how it's affecting the blood.
  • Patients usually start treatment with plasma exchange (PE) and may also receive medications like glucocorticoids, rituximab, and caplacizumab to help improve their condition.
  • A study showed that using caplacizumab can reduce repeated episodes and speed up recovery, but there are some risks, like bleeding, which mostly get better on their own.
View Article and Find Full Text PDF
Article Synopsis
  • Brody disease (BD) is an ultra-rare genetic disorder affecting muscle function due to a deficiency in the SERCA protein, leading to stiffness and delayed muscle relaxation after exercise.
  • There are currently no specific therapies or mouse models for BD, making it an orphan disease; however, bovine congenital pseudomyotonia serves as a mammalian model to study the condition.
  • This study focuses on the "acctq206" zebrafish variant as a potential model for testing new treatments, emphasizing the need for preclinical research before moving to human clinical trials.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!